$4.440
-0.098 (-2.20%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GTBP Prediction & Forecast by Similar Chart Analysis
Alphio's GTBP stock price prediction model matches the current GT Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.43 (-0.19%). The 1-week path is $4.41 (-0.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy GT Biopharma Inc Stock?
GT Biopharma Inc is not a good buy right now due to a significant net loss of $28.4 million for FY2025 and a current RSI of 23.39, indicating oversold conditions but also potential ongoing weakness. The stock has dropped 78.26% year-to-date, reflecting severe market challenges and investor sentiment issues.
GTBP stock price ended at $4.44 on Friday, after losing -2.20%
GT Biopharma Inc (GTBP) last closed at $4.4400001, losing -2.20%. These facts feed the 1-day and 1-week GTBP price prediction above.
Forecast Drivers
GT Biopharma Inc (GTBP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GTBP, ranked by similarity.
Seasonality analysis for GTBP
Historically the probability of a positive November return for GTBP is 0.00%. June offers the highest probability of a positive month at 16.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GTBP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.97 | $2.17 | $2.56 | -51.03% |
| Dec 2026 | $2.03 | $2.26 | $2.28 | -49.05% |
In 2026, GT Biopharma Inc (GTBP) is projected to range from $1.97 to $2.56.
GT Biopharma Inc 2026 monthly forecast
In Nov 2026, GT Biopharma Inc is projected to average $2.17, with a low of $1.97 and high of $2.56.
In Dec 2026, GT Biopharma Inc is projected to average $2.26, with a low of $2.03 and high of $2.28.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.